JPS6118544B2 - - Google Patents
Info
- Publication number
- JPS6118544B2 JPS6118544B2 JP2051178A JP2051178A JPS6118544B2 JP S6118544 B2 JPS6118544 B2 JP S6118544B2 JP 2051178 A JP2051178 A JP 2051178A JP 2051178 A JP2051178 A JP 2051178A JP S6118544 B2 JPS6118544 B2 JP S6118544B2
- Authority
- JP
- Japan
- Prior art keywords
- polyamine
- spermine
- fraction
- acid
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000768 polyamine Polymers 0.000 claims description 16
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 14
- 229940063675 spermine Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 241000868182 Thermus thermophilus HB8 Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2051178A JPS55302A (en) | 1978-02-24 | 1978-02-24 | Polyamine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2051178A JPS55302A (en) | 1978-02-24 | 1978-02-24 | Polyamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55302A JPS55302A (en) | 1980-01-05 |
| JPS6118544B2 true JPS6118544B2 (ko) | 1986-05-13 |
Family
ID=12029174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2051178A Granted JPS55302A (en) | 1978-02-24 | 1978-02-24 | Polyamine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55302A (ko) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200036900A (ko) | 2017-08-31 | 2020-04-07 | 캐논 가부시끼가이샤 | 초미세 기포 생성 방법, 초미세 기포-함유액 제조 장치 및 제조 방법, 및 초미세 기포-함유액 |
| EP3702331A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| EP3702022A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| EP3703467A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating apparatus |
| EP3702332A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| WO2021085629A1 (ja) | 2019-10-31 | 2021-05-06 | キヤノン株式会社 | ウルトラファインバブル含有液の製造方法、ウルトラファインバブル含有液、ウルトラファインバブルの活用方法、及びウルトラファインバブルの活用装置 |
| WO2021085637A1 (ja) | 2019-10-31 | 2021-05-06 | キヤノン株式会社 | 細胞の培養方法、培養液の製造方法、培養液及び培養装置 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114525230B (zh) * | 2022-03-31 | 2024-04-09 | 杭州优玛达生物科技有限公司 | 发酵培养物及嗜热栖热菌采用发酵培养物的发酵方法 |
-
1978
- 1978-02-24 JP JP2051178A patent/JPS55302A/ja active Granted
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200036900A (ko) | 2017-08-31 | 2020-04-07 | 캐논 가부시끼가이샤 | 초미세 기포 생성 방법, 초미세 기포-함유액 제조 장치 및 제조 방법, 및 초미세 기포-함유액 |
| EP3702331A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| EP3702022A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| EP3703467A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating apparatus |
| EP3702332A1 (en) | 2019-02-28 | 2020-09-02 | Canon Kabushiki Kaisha | Ultrafine bubble generating method, ultrafine bubble generating apparatus, and ultrafine bubble-containing liquid |
| WO2021085629A1 (ja) | 2019-10-31 | 2021-05-06 | キヤノン株式会社 | ウルトラファインバブル含有液の製造方法、ウルトラファインバブル含有液、ウルトラファインバブルの活用方法、及びウルトラファインバブルの活用装置 |
| WO2021085637A1 (ja) | 2019-10-31 | 2021-05-06 | キヤノン株式会社 | 細胞の培養方法、培養液の製造方法、培養液及び培養装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55302A (en) | 1980-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cohen et al. | Cytidine Deaminase from Escherichia coli: Purification, properties, and inhibition by the potential transition state analog 3, 4, 5, 6-tetrahydrouridine | |
| ISONO et al. | DEALANYLASCAMYCIN, NUCLEOSIDE ANTIBIOTICS FROM STREPTOMYCES SP. | |
| Uno et al. | Metabolism of adenosine 3′, 5′-cyclic monophosphate and induction of fruiting bodies in Coprinus macrorhizus | |
| Gloux et al. | Transport and catabolism of proline betaine in salt-stressed Rhizobium meliloti | |
| Masood et al. | 2'-Fluoro-2', 3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2', 3'-dideoxyadenosine | |
| JPS6118544B2 (ko) | ||
| Duerre et al. | Formotion and metabolism of S-adenosyl-l-homocysteine in yeast | |
| Gibson et al. | Transphosphorylations between nucleoside phosphates | |
| JPH0357760B2 (ko) | ||
| Tyerman et al. | Identification of glutamine chain lengths of endogenous Folypoly-γ-glytamates in rat tissues | |
| US4141972A (en) | Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation | |
| TW et al. | Studies on the biosynthesis of riboflavin. 3. The utilization of 14C-labelled serine for riboflavin biosynthesis by Eremothecium ashbyii. | |
| Fankhauser et al. | A nucleotide with the properties of adenosine 5′ phosphoramidate from Chlorella cells | |
| HIGASHI et al. | Studies on the Isocitrate Dehydrogenase I. Some Properties of Isocitrate Dehydrogenase of Beef Heart Muscle | |
| JPS603832B2 (ja) | アデノシン・三リン酸の製造法 | |
| Cooke et al. | The synthesis and some properties of a spin label analogue of adenosine 5'-triphosphate | |
| Yee et al. | Confirmation of a ping-pong mechanism for S-adenosyl-L-methionine: magnesium protoporphyrin methyltransferase of etiolated wheat by an exchange reaction | |
| JPH07113024B2 (ja) | ピロロキノリンキノンの精製方法 | |
| JPS5928470A (ja) | バチルス・ズブチリス | |
| Eloranta et al. | Uptake and utilization of 5'-methylthioadenosine by cultured baby-hamster kidney cells | |
| US20080103303A1 (en) | Chemical Synthesis Of S-Adenosyl-L-Methionine With Enrichment Of (S,S)-Isomer | |
| WO2003020945A2 (en) | An enzymatic process for the synthesis of organo-fluorine compounds | |
| Lee et al. | Comparative antineoplastic activity against p388 leukemia of 9‐β‐d‐arabinofuranosyladenine (area) and 9‐β‐(2′‐azido‐2′‐deoxy‐d‐arabinofuranosyl) adenine (arazide) | |
| Davis et al. | The isolation of intermediary metabolites of l-lysine-U-C14 from tissues of tumor-bearing rats | |
| Halper et al. | Rapid purification of pig heart fumarase by general ligand chromatography |